The Malignant Brain Tumor (MBT) Domain Protein SFMBT1 Is an Integral Histone Reader Subunit of the LSD1 Demethylase Complex for Chromatin Association and Epithelial-to-mesenchymal Transition
Authors:
Open Access
- 1 September 2013
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (38) , 27680-27691
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Corepressor-dependent silencing of fetal hemoglobin expression by BCL11AProceedings of the National Academy of Sciences, 2013
- SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factorsGenes & Development, 2013
- Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repressionProceedings of the National Academy of Sciences, 2012
- Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breastBMC Clinical Pathology, 2012
- Enhancer decommissioning by LSD1 during embryonic stem cell differentiationNature, 2012
- LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesisProceedings of the National Academy of Sciences, 2009
- TGF-β-induced epithelial to mesenchymal transitionCell Research, 2009
- Blocking of p53-Snail Binding, Promoted by Oncogenic K-Ras, Recovers p53 Expression and functionNeoplasia, 2009
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nature Reviews Cancer, 2007
- Androgen Receptor Coactivators Lysine-Specific Histone Demethylase 1 and Four and a Half LIM Domain Protein 2 Predict Risk of Prostate Cancer RecurrenceCancer Research, 2006